The updated European League Against Rheumatism (EULAR) guideline recommends cardiovascular disease (CVD) risk assessment at least once every 5 years in all patients with rheumatoid arthritis (RA). This viewpoint starts with a literature overview of studies that investigated the level of CVD risk factor (CVD-RF) screening in patients with RA in general practices or in outpatient clinics. These studies indicate that CVD-RF screening in patients with RA is marginally applied in clinical practice, in primary as well as secondary care. Therefore, the second part of this viewpoint describes an example of the successful implementation of the EULAR cardiovascular disease risk management (CVRM) guideline in patients with RA in a region in the south of the Netherlands where rheumatologists and general practitioners (GPs) closely collaborate to manage the cardiovascular risk of patients with RA. The different components of this collaboration and the responsibilities of respectively primary and secondary care professionals are described. Within this collaboration, lipid profile was used as an indicator to assess whether CVD-RF screening was performed in the previous 5 years. In 72% (n=454) of the 628 patients with RA, a lipid profile was determined in the previous 5 years. As part of routine quality control, a reminder was sent to the GP in case a patient with RA was not screened. After sending the reminder letter, in 88% of all patients with RA, CVD risk assessment was performed. This collaboration can be seen as good practice to provide care in line with the EULAR guideline.

中文翻译：

---

在类风湿性关节炎患者中实施 EULAR 心血管风险管理指南：初级和二级保健之间成功合作的结果

更新后的欧洲抗风湿联盟 (EULAR) 指南建议对所有类风湿性关节炎 (RA) 患者至少每 5 年进行一次心血管疾病 (CVD) 风险评估。这一观点始于对一般实践或门诊中 RA 患者的 CVD 风险因素 (CVD-RF) 筛查水平的研究的文献概述。这些研究表明 RA 患者的 CVD-RF 筛查在临床实践、初级和二级保健中的应用很少。所以，本观点的第二部分描述了在荷兰南部的一个地区，风湿病学家和全科医生 (GP) 密切合作管理 RA 患者的 EULAR 心血管疾病风险管理 (CVRM) 指南的成功实施示例。 RA 患者的心血管风险。描述了这种合作的不同组成部分以及初级和二级保健专业人员的职责。在这次合作中，血脂状况被用作评估过去 5 年是否进行了 CVD-RF 筛查的指标。在 628 名 RA 患者中，72% (n=454) 确定了过去 5 年的血脂谱。作为常规质量控制的一部分，如果未筛查 RA 患者，则会向 GP 发送提醒。发送提醒信后，88% 的 RA 患者进行了 CVD 风险评估。这种合作可以被视为提供符合 EULAR 指南的良好实践。